Gitlife Biotech

GitLife Biotech is a pioneering deep-tech company at the forefront of synthetic biology, offering a robust bio-digital platform (CellRepo) to improve identification and traceability of engineered biological assets for improved intellectual property (IP) protection, proof of provenance, secure collaboration and enhanced traceability to alleviate biosecurity concerns. Too many biotech breakthroughs get lost, stolen, or stuck in IP limbo. It’s not your research that’s failing. It’s the tools meant to protect it. 🧬 In fast-moving biotech environments, proving ownership shouldn’t be a guessing game. But today’s systems offer little to no visibility into who created what, when, or how. That leads to disputes, delays, and lost revenue, especially in IP-heavy fields like synthetic biology. After speaking with hundreds of scientists, R&D managers, and innovation leads, here’s what we’ve learned: • Most teams still rely on outdated manual tracking • IP is often left exposed due to lack of version control • Even when teams innovate fast, they can't always prove it That’s why we created CellRepo (GitLife). A single collaborative platform to trace, build, protect, and share bio-innovation. From early research to commercialization, GitLife brings structure, traceability, and security at every step of development. Think of it like version control for biology (GitHub for Biology): Barcoded, traceable cells that act like "PDFs for your strains" A clear, tamper-proof chain of custody for every asset Instant proof of ownership that speeds up funding, licensing, and innovation Seamless integration into your existing lab workflows